Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Motrin's "strong performance" helps J&J second quarter but consumer sales still down.

This article was originally published in The Tan Sheet

Executive Summary

McNEIL MOTRIN "STRONG PERFORMANCE" HELPS J&J CONSUMER SALES in the second quarter; however, the segment as a whole showed a sales decline for both the quarter and the half. Consumer product sales were helped by "strong performances from the adult and children's Motrin line of analgesics," as well as lead by "continued strength" in the company's skin care franchise, including the Neutrogena, RoC and Clean & Clear lines, Johnson & Johnson announced July 14.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088674

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel